EUVIMEDEUVIMED entdecken
Crossref

Inclusion Complex of Nimodipine with Sulfobutylether-β-cyclodextrin: Preparation, Characterization, In Vitro and In Vivo Evaluation

Jiahui Liu, Meichai Li, Yongjie Huang, Xinyu Wang, Youfa Xu, Zhiqin Fu, Zhizhe Lin, Jianming Chen, Xin Wu

AAPS PharmSciTech · 08.01.2025 · 26 (1)

DOI: 10.1208/s12249-024-03014-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AAPS PharmSciTech, online erschienen am 08.01.2025. Verfasst von Jiahui Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China. Hauptthemen laut MEDLINE: beta-Cyclodextrins, Nimodipine, Solubility. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nimodipine (NIMO) is used to treat ischemic nerve injury from subarachnoid hemorrhage (SAH), but its low aqueous solubility limits clinical safety and bioavailability. This study aims to improve NIMO's solubility by preparing inclusion complexes with sulfobutylether-β-cyclodextrin (SBE-β-CD), reducing the limitations of Nimotop® injection, including vascular irritation, toxicity, and poor dilution stability. The NIMO-SBE-β-CD inclusion complex (NIMO-CD) was characterized in both liquid and solid states through phase solubility studies and methods including DSC, FT-IR, XRD, and SEM. Dilution stability, hemolysis, vascular irritation, and acute toxicity tests were performed, with pharmacokinetic and pharmacodynamic studies using Nimotop® as the control. Physical characterization confirmed the successful formation of the inclusion complex. NIMO's solubility improved by 1202-fold (from 0.82 to 986.19 μg/mL at 25℃). NIMO-CD showed stability for 24 h when diluted, exhibited no hemolytic activity, reduced vascular irritation, and its median lethal dose (LD50) was 2.49 times higher than that of Nimotop®. Both NIMO-CD and Nimotop® displayed similar pharmacokinetic profiles. Behavioral assessments (mNSS scoring and CT), along with evaluations of hematoma area and histopathology, demonstrated that NIMO-CD significantly improved outcomes in intracerebral hemorrhage, greatly enhancing neurological recovery, reducing hematoma and edema, and achieving treatment effects comparable to those of Nimotop® injection. NIMO-CD significantly improves NIMO's solubility and stability while maintaining bioequivalence with Nimotop®. Furthermore, its enhanced safety profile indicates its potential as a superior formulation for treating ischemic nerve injuries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-CyclodextrinsNimodipineSolubilityAnimalsMaleRatsBiological AvailabilityHemolysisRats, Sprague-DawleyDrug StabilityMiceSpectroscopy, Fourier Transform InfraredChemistry, Pharmaceutical

Stichwörter der Autor:innen

NIMO-CDbiosafetyinclusion complexintracerebral hemorrhagenimodipinesulfobutylether-β-cyclodextrin

Substanzen

beta-CyclodextrinsSBE4-beta-cyclodextrinNimodipine

Autor:innen und Institutionen

  • Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China.
  • Shanghai Wei Er Lab, Shanghai, China.
  • Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China. chenjm0711@163.com.
  • Shanghai Wei Er Lab, Shanghai, China. chenjm0711@163.com.
  • Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China. wuxin007@126.com.
  • Shanghai Wei Er Lab, Shanghai, China. wuxin007@126.com.

Zitieren

APA

Liu, J., Li, M., Huang, Y., Wang, X., Xu, Y., Fu, Z., Lin, Z., Chen, J., & Wu, X. (2025). Inclusion Complex of Nimodipine with Sulfobutylether-β-cyclodextrin: Preparation, Characterization, In Vitro and In Vivo Evaluation. AAPS PharmSciTech, 26(1). https://doi.org/10.1208/s12249-024-03014-2

Vancouver

Liu J, Li M, Huang Y, Wang X, Xu Y, Fu Z, et al. Inclusion Complex of Nimodipine with Sulfobutylether-β-cyclodextrin: Preparation, Characterization, In Vitro and In Vivo Evaluation. AAPS PharmSciTech. 2025;26(1). doi:10.1208/s12249-024-03014-2

BibTeX
@article{Liu2025,
  author = {Liu, Jiahui and Li, Meichai and Huang, Yongjie and Wang, Xinyu and Xu, Youfa and Fu, Zhiqin and Lin, Zhizhe and Chen, Jianming and Wu, Xin},
  title = {Inclusion Complex of Nimodipine with Sulfobutylether-β-cyclodextrin: Preparation, Characterization, In Vitro and In Vivo Evaluation},
  journal = {AAPS PharmSciTech},
  year = {2025},
  volume = {26},
  number = {1},
  doi = {10.1208/s12249-024-03014-2}
}
Kostenlos starten →